Mark Sawicki - Aug 11, 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Scientific Officer
Signature
/s/ Mark Sawicki
Stock symbol
CYRX
Transactions as of
Aug 11, 2021
Transactions value $
-$3,935,607
Form type
4
Date filed
8/13/2021, 04:46 PM
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $605K +77.6K +215.19% $7.80 114K Aug 11, 2021 Direct
transaction CYRX Common Stock Options Exercise $143K +16.6K +14.58% $8.65 130K Aug 11, 2021 Direct
transaction CYRX Common Stock Sale -$4.35M -74.5K -57.15% $58.37 55.8K Aug 11, 2021 Direct F3
transaction CYRX Common Stock Sale -$188K -3.17K -5.68% $59.11 52.7K Aug 11, 2021 Direct F4
transaction CYRX Common Stock Sale -$151K -2.52K -4.79% $59.83 50.1K Aug 11, 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Option to purchase common stock Options Exercise $0 -77.6K -100% $0.00* 0 Aug 11, 2021 Common Stock 77.6K $7.80 Direct F1
transaction CYRX Option to purchase common stock Options Exercise $0 -16.6K -24.38% $0.00 51.4K Aug 11, 2021 Common Stock 16.6K $8.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48 of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
F2 1/48 of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.85 to $59.51, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.81 to $59.90, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.